Deciphering host--viral interactions {#sec0005}
====================================

Viruses constantly adapt to and transform their host environment to enable their replication and propagation [@bib0005], [@bib0010], [@bib0015], [@bib0020], [@bib0025], [@bib0030], [@bib0035], [@bib0040]. They do so, in part, through molecular interactions with host proteins that often modify their regular endogenous function. Although viral genomes were the first to be completely sequenced -- owing to their relatively small size [@bib0045] -- their encoding proteins and the modified proteomes of their host are only now being elucidated [@bib0050], [@bib0055]. These studies have revealed some fascinating intricacies such as multifunctional enzymes [@bib0060] and alternative open reading frames within viral genomes [@bib0065], [@bib0070]. With the successful sequencing of the human genome and the genome of other model host organisms, the current challenge is to be able to monitor the effects of viral infections on the host proteome, to uncover novel host--virus interactions and to discover how these perturbations affect cell function, viral propagation and disease progression. Ultimately, new methods are being developed to obtain a better understanding of the mechanisms of viral pathogenesis.

Conventional abundance-based viral proteomics {#sec0010}
=============================================

Similar to microarray technology that enabled global gene expression analyses, advances in high-throughput mass spectrometry (MS) technologies have revolutionized both specific and global protein analyses. Coupled with 2D gel electrophoresis, LC-MS/MS (see [Glossary](#glo0005){ref-type="glossary"}) analysis of tryptic fragments derived from protein digests has been commonly used to detect abundance changes in both viral and host proteomes in response to viral infections [@bib0075], [@bib0080], [@bib0085], [@bib0090], [@bib0095], [@bib0100], [@bib0105]. This technique has unveiled several proteins that play important roles during the pathogenesis of human immunodeficiency virus (HIV) [@bib0110], hepatitis C virus (HCV) [@bib0115], severe acute respiratory syndrome (SARS) [@bib0120], encephalomyocarditis virus [@bib0125], and simian virus 40 [@bib0130]. To overcome gel-to-gel variation, 2D differential gel electrophoresis technique (2D-DIGE) has been developed to study differences between two proteome samples (i.e. pathogenic versus non-pathogenic). In the 2D-DIGE approach, both samples are labeled with a unique fluorescent dye and are subsequently detected in the same 2D gel. Differentially expressed or sample-specific proteins are readily detected and analyzed based on their distinctive colored spots [@bib0135]. 2D-DIGE has been applied to study the host--virus interactions in several viral infections such as HIV [@bib0140], Dengue virus [@bib0095], and SARS [@bib0100].

Precise quantification of differentially expressed proteins is difficult to obtain by simply examining a gel. Alternatively, gel-free methods such as 'stable isotope labeling with amino acids in cell culture' (SILAC) have been used to quantify more accurately the intricate changes in host proteins caused by viral infections [@bib0145], [@bib0150], [@bib0155], [@bib0160], [@bib0165]. Specifically, SILAC has been utilized to detect changes in both viral and host proteomes in response to many viral infections including those with coronaviruses [@bib0145], HIV [@bib0160], influenza A virus [@bib0155], pseudorabies virus [@bib0090], and HCV [@bib0170].

Despite the significant findings resulting from these abundance-based approaches, all of these examples fail to capture many dynamic changes such as post-translational modifications, proteolytic processing, and association with cofactors and regulatory proteins that influence the activity of enzymes and their zymogens. Applications of activity-based protein profiling (ABPP) for studying host--viral systems have identified host enzymes that are differentially regulated during viral propagation. For example, ABPP has been used to identify human carboxylesterase 1 (CES1) being essential for efficient HCV propagation [@bib0175], and has been used to aid characterization of the previously unknown ubiquitin protease catalytic active site of the tegument protein of several herpesviridae members [@bib0180], [@bib0185], [@bib0190], [@bib0195], [@bib0200]. Also, ABPP has led the discovery of a new promising antiviral tetrahydroquinoline oxocarbazate cathepsin L inhibitor that abolishes SARS and Ebola virus entry [@bib0205] ([Table 1](#tbl0005){ref-type="table"} ).Table 1Representative activity-based probes and their application in diagnostic/therapeutic virologyProbe structureEnzyme classVirusApplicationsRefs**Mechanism-based ABPs**![](fx1.gif)Serine hydrolasesHCVCES1 influences cellular lipid metabolism during HCV replication and infection[@bib0175]![](fx2.gif)Kaposi-sarcoma-associated herpesvirus proteasesHHVActive site inhibition regulates the binding affinity of monomer-dimer equilibrium at the spatially separate dimer interface of the protease[@bib0385]**Substrate-based ABPs**  ![](fx3.gif)Proteases, hydrolases, oxidoreductases and isomerasesHCVIdentified several differentially active proteins during HCV replication[@bib0285]![](fx4.gif)USPs and UCHsEBV and HPV1Activities of USP5, -7, -9, -13, -15 and -22 as well as UCH-L1 and -L3 are upregulated during viral infections[@bib0310]![](fx5.gif)NeuraminidasesInfluenza A virus (H1N1)Mechanism-based ABPP of neuraminidases[@bib0355]![](fx6.gif)USP and UCHHPV1UCH-L1, UCH-L3, USP7, and USP9X show enhanced activity following transduction of HPV E6/E7[@bib0315]![](fx7.gif)HSV-1Identified UL36USP, encoded by HSV-1 genome. UL36USP activity peaks at late stages of viral replication and appears to require proteolytic processing from full-length UL36.[@bib0185]![](fx8.gif)human cytomegalovirusIdentified a high molecular weight protein as a functional deubiquitinase and that this enzyme activity was not absolutely essential for production of infectious virus.[@bib0195]![](fx9.gif)MDVIdentification of the catalytic active cysteine of the MDV large tegument protein and the oncogenic potential of MDV in chickens[@bib0200]![](fx10.gif)Cysteine proteasesEbola virus and SARS-CoVInhibitor of human cathepsin L that blocked SARS-CoV and Ebola pseudotype virus entry into human cells[@bib0205]![](fx11.gif)Caspase cysteine proteasesmurine norovirus (MNV-1)Identification of cathepsin B as upstream activator of the intrinsic apoptotic pathway induced by MNV[@bib0395]**Non-directed ABPs**  ![](fx12.gif)Isomerase, nucleotide binding, electron transport, structural, chaperone, hydrolase, transferase, oxidoreductase and protein bindingHCVIdentified nine differentially active enzymes during HCV propagation[@bib0275][^1]

ABPP {#sec0015}
====

ABPP was developed to determine the changes in the catalytic state of enzymes in complex proteomes [@bib0210], [@bib0215], [@bib0220] and to ascribe previously unknown enzymatic functions to proteins [@bib0225]. ABPP uses active-site-directed covalent probes (activity-based probes, ABPs) consisting of a reactive group linked to a reporter tag ([Figure 1](#fig0005){ref-type="fig"}a). Often, these ABPs are designed with the intention of exploiting conserved mechanistic features of their targeted enzyme superfamily [@bib0210], [@bib0230], [@bib0235], [@bib0240]. The reaction between the ABP and its active protein target usually results in an irreversible covalent bond ([Figure 1](#fig0005){ref-type="fig"}c), which facilitates subsequent analysis through the reporter tag. The reporter tag is generally a fluorophore for detection and visualization by in-gel fluorescence scanning, or biotin for purification of labeled enzymes ([Figure 1](#fig0005){ref-type="fig"}a).Figure 1ABPP is a functional proteomics technique that uses ABPs to react covalently with the active site of mechanistically related classes of enzymes. **(a)** The chemical structure of an ABP consists of two essential components: a warhead reactive group (e.g. small molecule inhibitors, substrate-based scaffolds or protein-reactive molecules) that covalently targets the catalytic amino acid residue of an enzyme active site, and a reporter tag (fluorophore or biotin) for detection or purification. The linker region is a flexible chain of varying length and hydrophobicity that connects and acts as a spacer between the warhead and the bulky fluorophore tag. **(b)** A clickable linker most commonly exploits copper-catalyzed N~3~--alkyne cycloaddition to couple a chemically inert alkyne (≡) group on the ABP to an N~3~ group on the reporter tag. Click chemistry has been applied to the field of ABPP, allowing the active proteome to be labeled *in situ* and *in vivo*. **(c)** Examples of the three main classes of ABPs and reaction with their respective enzyme targets. Upper panel: mechanism-based ABPs are based on irreversible enzyme inhibitors, such as fluorophosphonate, and form a covalent bond with the catalytic nucleophile amino acid residue in the active site of the targeted enzyme. Depicted here is a fluorophosphonate ABP targeting a member of the serine hydrolase superfamily. Middle panel: substrate-directed ABPs depend on substrate-based scaffolds (usually an amino acid residue or a peptide, such as ubiquitin) that act as a specificity region targeting the probe to the catalytic active site of the enzyme. Following recognition of the substrate-based scaffold, the catalytic nucleophile of the enzyme (Enz^--^) cleaves the scissile bond in proximity of the substrate scaffold to generate anion (X^--^) that facilitates departure of the fluoride leaving group (F^--^), generating a highly reactive electrophilic quinolimine methide intermediate, that reacts with a nucleophilic residue (Y^--^) within the enzyme active site to bind covalently the probe to the enzyme. Lower panel: non-directed ABPs contain a mild reactive group of electrophiles, such as sulfonate ester, that have intermediate reactivity; enough to modify the catalytic nucleophile amino acids in their activated state, but low enough to prevent unspecific labeling of other nucleophile residues outside the active site. Depicted here is the sulfonate ester ABP that targets several mechanistically distinct classes of enzymes. A more detailed description of the different ABP classes, the history and discovery of warhead reactive groups and the ABP labeling mechanisms can be found elsewhere [@bib0210].

ABPs are divided into at least three different classes based on the nature of their warhead reactive groups: mechanism-based ABPs, substrate-based ABPs and non-directed ABPs ([Figure 1](#fig0005){ref-type="fig"}c and [Table 1](#tbl0005){ref-type="table"}). Mechanism-based ABPs (also known as directed ABPs) contain an electrophilic reactive group that forms a covalent bond to the catalytic amino acid residue of the target enzyme active site ([Figure 1](#fig0005){ref-type="fig"}c). Examples of class-wide mechanism-based ABPP probes include fluorophosphonate, phosphonate esters, modified fluoroglycosides, and natural products like wortmannin and microcystin that target serine hydrolase, glycosidase, kinase and threonine phosphatase families, respectively [@bib0245], [@bib0250], [@bib0255], [@bib0260].

Although mechanism-based ABPs are effective in targeting enzyme families with known covalent inhibitors, many enzyme classes do not use conserved active-site nucleophiles or electrophiles to catalyze their enzymatic reactions and thus cannot form covalent adducts with mechanism-based suicide inhibitors. To broaden the number of enzyme classes addressable by ABPP, non-directed ABPs that contain mild electrophilic reactive group were developed ([Figure 1](#fig0005){ref-type="fig"}c) [@bib0265], [@bib0270]. For example, non-directed sulfonate ester [@bib0265], [@bib0275], α-chloroacetamide [@bib0280], and spiroepoxide [@bib0050] probes have been used to successfully label different enzyme families with various cellular roles.

Substrate-based ABPs are another class of ABPs that exploit the versatility of chemical scaffolds that take advantage of substrate selectivities within certain families of proteins (usually an amino acid residue or peptide) ([Figure 1](#fig0005){ref-type="fig"}a). Substrate-based scaffolds can be used as a specificity region to target the probe to the enzyme active site ([Figure 1](#fig0005){ref-type="fig"}c) [@bib0285], [@bib0290], [@bib0295], [@bib0300], [@bib0305]. By targeting a multitude of protein candidates with diverse range of functions and substrate preferences, this provides a better understanding of the degree to which viruses utilize host enzymes for replication and infection.

Several ABPP studies using these three ABP classes have recently been conducted in various viral systems ([Table 1](#tbl0005){ref-type="table"}). Herein, we highlight these with a focus on the various applications of ABPP including identification of dysregulated enzyme functions as a result of viral infection, assigning catalytic functions to previously uncharacterized viral proteins, visualization of the altered active proteome *in situ* during viral disease progression, and developing new antiviral therapeutics and viral diagnostics.

Comparative ABPP during viral infection {#sec0020}
---------------------------------------

Comparative ABPP ([Figure 2](#fig0010){ref-type="fig"}a) is the most common use of ABPP in virology ([Table 1](#tbl0005){ref-type="table"}). This approach, originally applied towards profiling applications, compares the differential activity between healthy and virus-infected host proteomes. Viral proteins and their altered host proteome are good candidates for comparative ABPP analyses, because viruses contain a manageable number of proteins, and viral infections involve coordinated host--virus interactions (e.g. attachment, cell entry, uncoating, replication, expression, virion assembly, and exit).Figure 2Applications of ABPP to study viral replication and infection. **(a)** Comparative ABPP has been extensively used to screen for differentially active enzymes during viral propagation with the potential to become therapeutic and diagnostic candidates. **(b)** Competitive ABPP is being used to screen inhibitor libraries and determine the specificity and sensitivity of potential therapeutics against both host and viral enzymes involved in the viral life cycle. **(c)** Comparative and imaging ABP probes have been used *in situ* by using the bioorthogonal click chemistry to monitor the variability of subcellular enzymatic activity induced by viral pathogenesis and the general experimental flow is depicted.

Several ABPs, such as the influenza hemagglutinin-tagged ubiquitin (HAUb)-derived bromoethylamine [@bib0310], HAUb vinylmethyl ester [@bib0310], [@bib0315] and fluorophosphonate [@bib0175] probes have been successfully used in comparative ABPP during viral infection ([Table 1](#tbl0005){ref-type="table"}). The application of ABPP towards the deubiquitinating enzyme family is of significant importance, because unlike Ub conjugation, very little is known about the removal of Ub from Ub conjugates and how they influence cellular processes during an infection. The HAUb group of the probe ([Table 1](#tbl0005){ref-type="table"}) is the substrate specificity region ([Figure 1](#fig0005){ref-type="fig"}a) that targets the probe to the active site of ubiquitin-specific protease (USP). The catalytic cysteine residue undergoes 1,4-conjugate addition with the vinylmethyl ester warhead group ([Figure 1](#fig0005){ref-type="fig"}a), creating a covalent bond with the probe ([Figure 1](#fig0005){ref-type="fig"}c, middle panel) [@bib0320]. By comparing the activity profiles of these ABPs in presence or absence of Epstein--Barr virus (EBV) and human papilloma virus (HPV) infections, several deubiquitinating enzymes have been shown to be upregulated, such as USP-5, -7, -9, -13 and -15 [@bib0310], as well as Ub carboxyl-terminal hydrolases (UCH)-L1 and -L3 [@bib0315]. One identified target, UCH-L1, is only upregulated very late during viral infection, correlating with increased cellular growth. The use of ABPP in human lymphomas and cervical cancer biopsies to measure the increased activity of UCH-L1 gives a more realistic understanding of how UCH-L1 activity is linked to malignant cellular proliferation [@bib0310], [@bib0315], rather than simply monitoring the enzymatic activity in cell lines or animal models. Significant efforts are currently underway to characterize this differentially active deubiquitinating enzyme and its downstream targets to elucidate further the molecular details leading to EBV- and HPV-induced malignancy [@bib0325].

Another promising target of comparative ABPP is CES1, an endogenous liver enzyme identified with a fluorophosphonate mechanism-based ABP ([Table 1](#tbl0005){ref-type="table"}, [Figure 1](#fig0005){ref-type="fig"}c upper panel) to monitor the differential activity of serine hydrolases during HCV replication and infection ([Figure 3](#fig0015){ref-type="fig"}a). CES1 activity not only correlates with HCV abundance, but also regulates HCV replication and infectivity in both cell culture and animal models ([Figure 3](#fig0015){ref-type="fig"}b) [@bib0175]. CES1 is a multifunctional enzyme that modulates intracellular neutral lipid (e.g. triglycerides and cholesterol esters) biosynthesis by displaying triacylglycerol hydrolase [@bib0330] and acyl-CoA:acyl transferase [@bib0335] enzymatic activities. Coherent anti-Stokes Raman scattering microscopy [@bib0340] has also been used to demonstrate that CES1 overexpression gives rise to a significant increase in lipid droplet size ([Figure 3](#fig0015){ref-type="fig"}b) [@bib0175]. CES1 is also involved in the transport of these neutral lipids into intracellular lipid droplets (LDs) for their subsequent secretion in very-low density lipoproteins (VLDLs) [@bib0330]. HCV is known to exploit the LD and VLDL cellular pathways for its own replication, virion assembly and budding [@bib0345], [@bib0350]. Also, HCV modulates the host metabolic pathways by increasing the activity of CES1 to alter the intracellular environment for its efficient replication and propagation ([Figure 3](#fig0015){ref-type="fig"}c) [@bib0175]. The ABPP discovery of CES1 and its role in increasing the intracellular lipid content during HCV propagation provides a better understanding of the development of liver steatosis (i.e. fatty liver), a phenotypic outcome found in many HCV-infected patients. Additionally, CES1 presents itself as a possible host target for the development of new antiviral therapeutics.Figure 3Schematic stepwise example of how the altered function of a differentially active protein identified by ABPP is linked to viral pathogenesis, such as HCV [@bib0175]. **(a)** The activity profile of serine hydrolases during HCV replication was obtained with a fluorophosphonate (FP) ABP. Following gel separation and comparison of the labeled proteomes from non-infected and HCV-infected hepatocytes, a differentially labeled protein was identified by LC-MS/MS to be human CES1. **(b)** To determine the effect of CES1 activity on HCV propagation, the expression of CES1 was knocked down and overexpressed while monitoring the levels of HCV. As CES1 activity was found to influence the HCV life cycle, its specific role during HCV propagation was narrowed down to the metabolism of inert lipids \[i.e. cholesterol esters (CEs) and triglycerides (TGs)\] and their storage into intracellular LDs. **(c--f)** Based on the findings that CES1 favors CE and TG loading in LDs, a hypothetical synergy between CES1 and HCV has been suggested: the HCV-induced high expression of the endoplasmic reticulum (ER) protein CES1 loads TGs and CEs in LDs, increasing their size and number **(d)**. **(e)** Upon LD saturation with these inert lipids, the ER--LD interstitial space increases, creating a favorable environment where high HCV replication occurs. **(f)** At the viral budding stage of HCV, an increase in the turnover dynamics of HCV particles allows CES1 and HCV to occupy the abundant LD--ER interface abundantly.

Non-directed comparative viral ABPP {#sec0025}
-----------------------------------

Although mechanism-based ABPP is effective in analyzing enzymes with known covalent inhibitors, substrate-based and non-directed probes have also been applied to broaden the activity-based profiling of host enzyme families that could be involved in viral replication and infection ([Table 1](#tbl0005){ref-type="table"}). By applying a non-directed sulfonate ester and a variety of substrate-based amino acid coupled quinolimine methide ABPs, we have identified several differentially active proteins during HCV replication that encompass many enzyme families [@bib0275], [@bib0285]. The broader specificity of the substrate-based ABP is likely attributed to the single amino acid composition of the probe and the electrophilic properties of the quinolimine methide intermediate [@bib0285]. The specificity of this probe would be improved by substituting the single amino acid with a di- or oligopeptide substrate, as shown with a tripeptide epoxide [@bib0205] and a hexapeptide diphenylphosphonate [@bib0355] ABPs discussed further below. Of the identified ABPP targets, heat shock protein 70, nuclear distribution gene C homolog, chaperonin containing TCP1, protein disulfide isomerase 1 and 6, cathepsin D and isochorismatase domain containing 1 have been observed to have altered activity during HCV replication, with virtually unchanged abundance. These differential activities, which are probably attributed to post-translational modifications or cofactor/inhibitor association, would have been undetected by other conventional proteomic techniques. The identification of these non-directed ABPP targets suggests that both combinatorial and mechanism-based ABPP methods can accelerate the discovery of protein activities associated with the pathogenic states of viral infections.

In situ/in vivo viral ABPP applications through click chemistry {#sec0030}
---------------------------------------------------------------

The early versions of ABPs were designed with bulky reporter groups (i.e. fluorophore or biotin), which limited their uptake and distribution in cells and tissues. Hence, the initial ABPP protocols restricted the usage of ABPs to *in vitro* experiments from homogenized cells or tissues. This resulted in a loss of cellular compartmentalization and altered the biodistribution of cofactors, inhibitors and binding partners essential for enzymatic regulation and probably did not represent the true functional state of the targeted enzymes [@bib0360], [@bib0365]. To provide a more physiologically relevant enzymatic profile, the enzymes needed to be assessed within the context of their native subcellular environments. To accomplish this, *in vivo* ABPs containing small bio-orthogonal reporter groups, typically terminal alkyne (≡) or azide (N~3~) ([Figure 1](#fig0005){ref-type="fig"}b), were developed. The small size of the bio-orthogonal reporter group greatly improves the ABP cell permeability and distribution in cells for *in situ* or *in vivo* proteome labeling. To visualize or isolate the enzymes bound to the alkyne ABPs, the alkyne-labeled proteome is subsequently reacted with N~3~ containing a reporter tag via a copper-catalyzed azide--alkyne cycloaddition, commonly referred to as a 'click chemistry' reaction ([Figure 1](#fig0005){ref-type="fig"}b) [@bib0370]. The *in situ* ABPP labeling technique has been shown by our group using a non-directed sulfonate ester alkyne (PS4≡) ABP during HCV replication and delivered significant labeling disparities between *in vitro* and *in situ* ABPP [@bib0275]. The number of protein candidates labeled *in situ* with the PS4≡ ABP doubled when compared to the *in vitro* labeling of the cell homogenate [@bib0275]. This demonstrates that catalytic activity is greatly influenced by the structural integrity of the enzyme and its native subcellular environment, and illustrates a key advantage of *in situ* and *in vivo* ABPP.

ABPP function assignment of uncharacterized viral proteins {#sec0035}
==========================================================

The relatively large DNA genomes of herpes viruses with 100--200 open-reading frames have made them a popular virus group for characterization by ABPP of novel catalytic functions of expressed viral gene products. Important advances have recently been made in characterizing the multifunctional activities of the highly variable tegument protein of several herpesviridae members using an HAUb vinylmethyl ester ABP ([Table 1](#tbl0005){ref-type="table"}) [@bib0180], [@bib0185], [@bib0190], [@bib0195], [@bib0200]. Despite sharing only 15% sequence similarity between some herpesviridae members [@bib0190], ABPP is able to identify an important conserved deubiquitinating enzymatic activity in the N-terminal segment of the murine [@bib0190] and human [@bib0195] cytomegaloviruses, EBV [@bib0190], herpes simplex virus 1 (HSV-1) [@bib0185], chicken Marek\'s disease virus (MDV) [@bib0200] and murine gammaherpesvirus 68 [@bib0180]. In one of these studies, the use of both mutagenesis and the HAUb vinylmethyl ester ABP led to the identification of the catalytically active cysteine of the MDV large tegument protein, and linked it to the oncogenic potential of MDV in chickens [@bib0200]. The deubiquitinating activity of these herpesviridae tegument proteins is believed to not only be implicated in viral gene transcription, cell cycle regulation and virion budding, but also in tumor development. Despite the immense complexity of the herpes genome, the highly conserved deubiquitinating catalytic site of the tegument protein among alpha-, beta-, and gamma-herpesviruses is of great potential for antiviral therapeutic development [@bib0185].

Similarly, another group has used a hexapeptide diphenylphosphonate ABP to study the activity of a poorly understood Kaposi-sarcoma-associated herpesvirus (human herpesvirus 8; HHV-8) protease ([Table 1](#tbl0005){ref-type="table"}) [@bib0355]. By characterizing the active site of HHV-8 protease through ABPP, its catalytic activity has been shown to depend on the quaternary structure of the resultant dimer, and that the active sites of the monomer are catalytically independent. The discovered link between the HHV-8 protease quaternary structure and catalytic activity offers an alternate inhibition strategy that could use the hexapeptide diphenylphosphonate ABP for developing and screening of substoichiometric inhibitors that could destabilize the dimeric interface [@bib0355].

Competitive ABPP for antiviral inhibitor screening {#sec0040}
==================================================

Given that viruses require a host for their propagation, they are more vulnerable to inhibition of cellular pathways. Conventional antiviral drugs have focused on selectively targeting viral gene products to minimize side effects experienced by the patient. The limited number of viral targets and the rapid emergence of drug-resistant viral mutations necessitate the search for host cell targets as alternatives for antiviral therapeutic development. As host--virus interactions become more apparent, ABPP can be used to screen for inhibitors of novel host targets through competitive assays. In these assays, relatively more potent inhibitors have been identified by their ability to block access of the ABP to the enzyme active site ([Figure 2](#fig0010){ref-type="fig"}b).

Competitive ABPP has recently been applied for screening and testing antiviral drugs against SARS coronavirus (CoV) and the Ebola pseudotype virus. A biotin tripeptide epoxide ABP (biotin-Lys-C5 alkyl linker-Tyr-Leu-epoxide or DCG-04) ([Table 1](#tbl0005){ref-type="table"}) has been used to determine the efficacy of a novel tetrahydroquinoline oxocarbazate CID 23631927 inhibitor against its host human cell cathepsin L target [@bib0205]. The endosomal cathepsin L is an appealing target for antiviral development, because it mediates viral entry by triggering the fusion of the plasma membrane with endosomes via proteolysis [@bib0375], [@bib0380]. The DCG-04 ABP revealed that the tetrahydroquinoline oxocarbazate inhibitor was cell permeable and reduced the activity of cathepsin L by 38% [@bib0205]. These findings demonstrate a potential role for DCG-04 ABP for identifying novel inhibitors, such as oxocarbazate inhibitor CID 23631927 that is a subnanomolar, slow-binding, reversible inhibitor of human cathepsin L, which prevents SARS and Ebola virus entry into human cells [@bib0205]. Further applications of the DCG-04 ABP could be to explore the mechanisms of viral entry and screen for other potent inhibitors.

Similarly, ABPs that target extracellular membrane proteins have been used in viral diagnostic development. A substrate-based sialic-acid-containing ABP probe incorporating an ortho-difluoromethylphenyl trapping moiety ([Table 1](#tbl0005){ref-type="table"}) has been immobilized to the surface of a microplate well and has successfully captured influenza virion particles through their neuraminidase surface glycoproteins [@bib0385]. The immobilization of influenza virion particles to functionalized surfaces via ABPs has the potential to accelerate the simultaneous screening of hundreds of antiviral antibodies and drugs. Furthermore, ABPs, such as substrate-based probes containing sialic acid and ortho-difluoromethylphenyl trapping moiety, could also influence viral diagnostics by generating unique activity profiles for dozens of viral species and strains to be matched against unknown specimens for identification.

ABPP for viral pathogenesis imaging {#sec0045}
===================================

The combination of live cell imaging with ABPP gives researchers the ability to monitor rapidly changes of subcellular enzymatic activity during viral pathogenesis in real time ([Figure 2](#fig0010){ref-type="fig"}c). Although not based on click chemistry ([Figure 1](#fig0005){ref-type="fig"}b), the sulforhodamine valylalanylaspartic acid fluoromethyl ketone (SR-VAD-fmk) poly caspase ABP ([Table 1](#tbl0005){ref-type="table"}) is cell-membrane-permeable [@bib0390], making it suitable for *in situ* and *in vivo* ABPP. The *in situ* application of SR-VAD-fmk on norovirus-infected mouse macrophage cells has shown that activation of caspase cysteine proteases occurred within 2 h of viral infection [@bib0395]. *In vitro* ABPP characterization studies have identified cathepsin B as a novel host enzyme that has increased activity during early viral infection [@bib0395]. This implies that the murine norovirus could take advantage of the cathepsin-B-induced apoptosis for its transfer in fragmented membrane bodies to neighboring cells.

Future virus ABPP perspectives {#sec0050}
==============================

While gel-based ABPP approaches are robust enough to identify abundantly expressed proteins, they lack the ability to identify low-abundance targeted proteins. A recent ABPP gel-free approach uses 2D liquid chromatography to enrich and identify ABPP-labeled protein targets in the presence of highly abundant unlabeled host protein contaminants (ABPP--MudPIT). This high-throughput characterization of labeled proteins, combined with the simultaneous identification of the probe-labeled sites (TOP--ABPP), could speed up the active site characterization of newly identified antiviral targets for therapeutic inhibitor screening [@bib0400]. Modern virology and antiviral drug discovery are thus expected to be progressively enhanced by new research involving viral ABPP. Activity-based technology currently targets over a dozen classes of enzymes [@bib0240]. As more covalent inhibitors are discovered, the repertoire of addressable enzyme families will increase to cover a larger portion of the active proteome. ABPP is a valuable technique for providing unique information on the enzymatically active proteome, which complements other large-scale profiling methods, such as abundance-based proteomics, SILAC, microarray, and systems biology approaches. The future challenges for the application of ABPP in virology will be to determine which of the myriad of host enzymes are essential for virus infection. These newly identified ABPP candidates will represent novel targets for the development of viral diagnostics and antiviral therapeutics.

ABPP-multidimensional protein identification (ABPP-MudPIT)

:   a high-throughput gel-free ABPP approach involving biotinylated ABPs to label the active proteome. Purification of the biotinylated ABP-labeled proteins with (strept)avidin beads allows for their enrichment to identify less abundant protein targets.

Bio-orthogonal functional group

:   A chemical moiety that is unreactive towards all functional groups found in biological systems but may undergo other reactions in the presence of specific molecules.

Comparative ABPP

:   an ABPP application that compares two or more proteomes and analyzes their differing activities.

Competitive ABPP

:   a competitive mode of ABPP in which specific inhibitors are identified by their ability to block access of the ABP to the enzyme active site.

LC-MS/MS

:   liquid chromatography--tandem mass spectrometry: an analytical technique where hydrolyzed protein fragments are separated by liquid chromatography and assessed for abundance through an initial mass spectrometer. The peptides are subsequently fragmented by collision induced dissociation to determine the original peptide sequence in a second mass spectrometer.

Proteome

:   an entire set of proteins expressed by a genome, cell, tissue or organism at a given time and biological state.

Stable isotope labeling with amino acids in cell culture (SILAC)

:   a quantitative proteomic technique that uses non-radioactive isotope labeling and LC-MS/MS to determine protein abundance.

Tandem-orthogonal proteolysis-ABPP (TOP-ABPP)

:   ABPP method to enrich specifically ABP-labeled peptide fragments while discarding the remaining digested proteome. The use of a tobacco etch virus proteolytic site in the ABP eliminates false positives to determine accurately the probe-labeled active site in the protein target.

[^1]: Abbreviations: ABP, activity-based probe; HAUb, hemagglutinin-tagged ubiquitin; HCV, hepatitis C virus; UCH, Ubiquitin C-terminal hydrolase; USP, Ubiquitin specific protease.
